Business Description
Genor Biopharma Holdings Ltd
ISIN : KYG3871A1004
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 326.1 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 55.2 | |||||
3-Year EPS without NRI Growth Rate | 53.9 | |||||
3-Year FCF Growth Rate | 40.1 | |||||
3-Year Book Growth Rate | -30.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.39 | |||||
9-Day RSI | 56.61 | |||||
14-Day RSI | 50.45 | |||||
6-1 Month Momentum % | 51.91 | |||||
12-1 Month Momentum % | 61.79 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.76 | |||||
Quick Ratio | 5.73 | |||||
Cash Ratio | 5.41 | |||||
Days Inventory | 15829.29 | |||||
Days Payable | 136686.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 3.45 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 97.59 | |||||
Operating Margin % | -3679.81 | |||||
Net Margin % | -3675.83 | |||||
FCF Margin % | -2363.68 | |||||
ROE % | -41.35 | |||||
ROA % | -34.63 | |||||
ROIC % | -185.02 | |||||
ROC (Joel Greenblatt) % | -526.02 | |||||
ROCE % | -39.84 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 51.94 | |||||
PB Ratio | 0.72 | |||||
Price-to-Tangible-Book | 0.86 | |||||
EV-to-EBIT | 0.68 | |||||
EV-to-EBITDA | 0.68 | |||||
EV-to-Revenue | -25.04 | |||||
EV-to-FCF | 0.94 | |||||
Price-to-Net-Current-Asset-Value | 0.95 | |||||
Price-to-Net-Cash | 1.01 | |||||
Earnings Yield (Greenblatt) % | 146.09 | |||||
FCF Yield % | -46.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genor Biopharma Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 1.853 | ||
EPS (TTM) (€) | -0.133 | ||
Beta | 0.54 | ||
Volatility % | 78.18 | ||
14-Day RSI | 50.45 | ||
14-Day ATR (€) | 0.004566 | ||
20-Day SMA (€) | 0.1644 | ||
12-1 Month Momentum % | 61.79 | ||
52-Week Range (€) | 0.0845 - 0.256 | ||
Shares Outstanding (Mil) | 516.51 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genor Biopharma Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genor Biopharma Holdings Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Genor Biopharma Holdings Ltd Frequently Asked Questions
What is Genor Biopharma Holdings Ltd(FRA:67N0)'s stock price today?
When is next earnings date of Genor Biopharma Holdings Ltd(FRA:67N0)?
Does Genor Biopharma Holdings Ltd(FRA:67N0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |